Diastolic function evaluation in children with ventricular arrhythmia

Radosław Pietrzak1, Tomasz M Książczyk2, Magda Franke2

  • 1Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, Żwirki I Wigury Street 61, 02-091, Warszawa, Poland. radoslaw.pietrzak@wum.edu.pl.

Scientific Reports
|April 11, 2023
PubMed

Insights

Children with premature ventricular contractions (PVC) show impaired left ventricular diastolic function, impacting their physical performance. This diastolic dysfunction worsens with increased arrhythmia burden, potentially affecting exercise capacity.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Physiology
  • Echocardiography

Background:

  • Premature ventricular contractions (PVC) are common in children, but their impact on cardiac function and physical performance requires further investigation.
  • Left ventricular systolic function is often normal in children with PVC, highlighting the potential role of diastolic function.

Purpose of the Study:

  • To evaluate left ventricular diastolic function in children with PVC and normal systolic function.
  • To determine if diastolic function disturbances in these children affect their physical performance.

Main Methods:

  • Compared echocardiographic diastolic function parameters (LAVI, LA strains, E/E', IVRT) between 36 PVC children and 33 healthy controls.
  • Assessed physical performance using cardiopulmonary exercise testing (CPET) to measure maximal oxygen uptake (VO2 max).

Main Results:

  • Significant differences in diastolic parameters (Edt, E/E', IVRT) and left atrial function (LAVI, AC-CT, AC-R) were observed in PVC children compared to controls.
  • A moderate, negative correlation was found between VO2 max and the E/E' ratio, indicating impaired diastolic function is linked to reduced exercise capacity.
  • Diastolic function was found to deteriorate with an increasing burden of ventricular arrhythmias.

Conclusions:

  • Left ventricular diastolic dysfunction is prevalent in children with PVC, even with normal systolic function.
  • Diastolic impairment in PVC children is associated with reduced exercise capacity.
  • Ventricular arrhythmias in young individuals may lead to elevated filling pressures and diminished exercise tolerance.

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
43
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
27
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14